Panel considers value of pharmacogenetic testing, fintech for benefits plans
As innovations in science and technology disrupt the status quo, developments such as pharmacogenetic testing in group benefits plans and robo-advisors in the pension industry are offering new options…
- By: Ryan Murphy
- November 24, 2017 September 13, 2019
- 08:30












